+52 55 1827 8370
someramexico@gmail.com
    Afiliarme

Biblioteca virtual

  1. Inicio
  2. Biblioteca virtual
Descubre artículos, guías y documentos especializados

Recursos académicos, investigaciones y materiales de referencia actualizados, diseñados para fortalecer la práctica médica y el aprendizaje continuo.

"Dosimetric evaluation of a hybrid treatment planning for whole-brain radiation with hippocampal sparing" International Journal of Radiation Research (2024): 22(2): 321-328 Somera

"Dosimetric evaluation of a hybrid treatment planning for whole-brain radiation with hippocampal sparing" International Journal of Radiation Research (2024): 22(2): 321-328

3. "Dosimetric evaluation of a hybrid treatment planning for whole-brain radiation with hippocampal sparing" International Journal of Radiation Research (2024): 22(2): 321-328 La irradiación a holocráneo con preservación de hipocampos busca reducir el deterioro neurocognitivo asociado a la radioterapia en pacientes con metástasis cerebrales. Este estudio evaluó una técnica híbrida que combina IMRT y VMAT en 15 pacientes. Los resultados mostraron mejor conformidad y homogeneidad del plan en comparación con las técnicas utilizadas por separado, mientras que las dosis a órganos de riesgo y el tiempo de tratamiento fueron intermedios. La técnica híbrida se presenta como una alternativa prometedora para optimizar la planificación dosimétrica en tratamientos de holocráneo con preservación de hipocampos.

Acceder
"Dosimetric study of a hybrid plan technique for external beam radiotherapy in patients with cervical cancer" Radiation and Environmental Biophysics (2021) 60:653–662 Somera

"Dosimetric study of a hybrid plan technique for external beam radiotherapy in patients with cervical cancer" Radiation and Environmental Biophysics (2021) 60:653–662

1. "Dosimetric study of a hybrid plan technique for external beam radiotherapy in patients with cervical cancer" Radiation and Environmental Biophysics (2021) 60:653–662 Este estudio comparó la calidad dosimétrica de planes de radioterapia IMRT, VMAT y una técnica híbrida que combina ambas modalidades en pacientes con cáncer cervicouterino. En un análisis retrospectivo de 20 casos, los planes híbridos mostraron mejor conformidad y homogeneidad en la cobertura del volumen blanco, así como reducción significativa de dosis en órganos de riesgo como vejiga y recto. Además, el número de unidades monitoras y el tiempo de tratamiento fueron intermedios respecto a IMRT y VMAT. Estos hallazgos sugieren que la planificación híbrida puede optimizar la calidad dosimétrica en radioterapia pélvica.

Acceder
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial Externo

Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial

Wei-Jian Mei, PhD 1; Xiao-Zhong Wang, MD 2 ; Xuan Zhang, PhD 3 ; Yue-Ming Sun, PhD 4; Chun-Kang Yang, PhD 5 ; Jun-Zhong Lin, PhD 1; Zu-Guang Wu, MD 6 ; Rui Zhang, PhD 7 ; Wei Wang, PhD 8; Yong Li, PhD 9,10; Ye-Zhong Zhuang, MD 11 ; Jian Lei, MD 12 ; Xiang-Bin Wan, PhD 13 ; Ying-Kun Ren, MD 13 ; Yong Cheng, PhD 14 ; Wen-Liang Li, PhD 15; Zi-Qiang Wang, MD 16; Dong-Bo Xu, MD 17 ; Xian-Wei Mo, PhD 18; Hai-Xing Ju, PhD 19 ; Sheng-Wei Ye, PhD 20 ; Jing-Lin Zhao, MD 21 ; Hong Zhang, PhD 22 ; Yuan-Hong Gao, PhD 23; Zhi-Fan Zeng, PhD 23 ; Wei-Wei Xiao, PhD 23; Xiao-Peng Zhang, MD 2 ; Yun-Feng Li, PhD 3 ; E Xie, MD 24 ; Yi-Fei Feng, MD 4 ; Jing-Hua Tang, PhD 1; Xiao-Jun Wu, PhD 1 ; Gong Chen, PhD 1 ; Li-Ren Li, PhD 1 ; Zhen-Hai Lu, PhD 1 ; De-Sen Wan, PhD 1 ; Jin-Xin Bei, PhD 25; Zhi-Zhong Pan, PhD 1 ; Jie-Hai Yu, PhD 1; andPei-Rong Ding, PhD 1 DOI https://doi.org/10.1200/

Acceder
MOSBY'S® Radiation Therapy Externo

MOSBY'S® Radiation Therapy

Mosby’s ® Radiation Therapy Study Guide and Exam Review SECOND EDITION Edited by Leia Levy, MAdEd, EdD, RT(T) Associate Professor Radiation Therapy Program Director Department of Natural and Health Sciences University of St. Francis Joliet, Illinois, United States

Acceder
RADIOTHERAPY TREATMENT PLANNING Linear-Quadratic Radiobiology Externo

RADIOTHERAPY TREATMENT PLANNING Linear-Quadratic Radiobiology

Dedicado a los físicos médicos y dosimetristas que a diario planifican y asisten en la administración de planes de oncología radioterápica a los pacientes. Sus esfuerzos a menudo pasan desapercibidos, pero son esenciales para desarrollar tratamientos curativos contra el cáncer.

Acceder
Real-WorldDataonBarrigelandSpaceOARRectalSpacersinProstateCancerRadiationTherapy:AComparativeAnalysis Externo

Real-WorldDataonBarrigelandSpaceOARRectalSpacersinProstateCancerRadiationTherapy:AComparativeAnalysis

Real-WorldDataonBarrigelandSpaceOARRectalSpacersinProstateCancerRadiationTherapy:AComparativeAnalysis ShrutiPrusty,MD,aDeborahCho,MD,aKenThong,MBBS,FRANZCR,bAlbertTiu,MBBS,MMED,FRACS,cNicholasMcLeod,BSc,BMed,FRACS,cLucyLeigh,PhD,BMath,BMRS,dJaradMartin,MBChB,PhD,DMed,BSc,a,eMichaelChao,MBBS,DMedSc,FRANZCR,fandEricWegener,MBBS,BMedSci,FRANZCRa,e,*

Acceder
Dose-VolumeHistogramCompendiumofDoseConstraintsforTreatmentPlanning:AnASTROConsensusPaper Externo

Dose-VolumeHistogramCompendiumofDoseConstraintsforTreatmentPlanning:AnASTROConsensusPaper

Purpose: This dose-volumehistogram(DVH)compendiumsharestheknowledgeandresourcescompiledbydisease-siteexpertsdur- ing animmenseundertakingbytheVeteransAffairs(VA)andAmericanSocietyforRadiationOncology(ASTRO)todevelopperfor- mance indicatorsforradiationtherapyaspartofqualitysurveillance.Theguidanceforbreast,headandneck,liver,lung,prostate,and rectal cancerssupportsphysiciandecision-makingduringdosimetrictreatmentplann

Acceder
Modulated Arc Therapy (mARC) versus intensity-modulated radiation therapy in craniospinal irradiation: Evaluation of CT-slice-defined field junction thickness on dosimetric quality Somera

Modulated Arc Therapy (mARC) versus intensity-modulated radiation therapy in craniospinal irradiation: Evaluation of CT-slice-defined field junction thickness on dosimetric quality

A B S T R A C T Background: One of the main technical challenges in craniospinal irradiation (CSI) is the risk of overdosing or underdosing in field overlap regions due to the need to match multiple treatment fields along the Planning Target Volume (PTV). To the authors’ knowledge, the technical and dosimetric feasibility of modulated arc therapy (mARC) has not yet been evaluated for CSI. Unlike other arc techniques, mARC delivers dose in discrete arcs. This study compared mARC with intensity-modulated radiation therapy (IMRT) and analyzed the impact of overlap region thickness, defined by the number of computed tomography (CT) slices, on plan quality. Methods: Treatment plans were generated for 10 patients using both mARC and IMRT on a Siemens Artiste linear accelerator. Optimization pseudo-structures were created with 4, 5, 6, and 7 tomographic slices at the craniothoracic and thoracolumbar junctions, resulting in eight plans per patient. The prescribed dose was 36 Gy in 20 fractions. Plans were evaluated by assessing PTV dosimetric parameters, doses to organs at risk (OARs), monitor units (MU), and treatment time. Statistical analysis employed two-way repeated-measures analysis of variance (ANOVA).

Acceder
Cancer predisposition syndromes: an imaging review Externo

Cancer predisposition syndromes: an imaging review

Abstract Background Cancer predisposition syndromes (CPSs) are inherited disorders that increase the risk of developing cancer from childhood through adulthood. They account for up to 10% of pediatric tumors, making early recognition important for reducing morbidity and mortality. Because these syndromes show variable penetrance and a wide range of clinical presentations even within the same family, identifying affected children can be challenging.

Acceder
ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancer Externo

ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancer

1. Introduction In recent years, the treatment paradigm for rectal cancer (RC) has increasingly shifted toward dose intensification strategies, aiming to enhance complete response (CR) rates [1,2]. Achieving CR is clinically meaningful, as it significantly increases the likelihood of organ preservation and functional sphincter-sparing outcomes—particularly critical in younger patients, for whom long-term quality of life (QoL) and avoidance of permanent colostomy are paramount [3,4] and older patients with comorbidities rendering them not suitable for surgery [5].

Acceder
ESTRO technical guideline: intensity modulated radiotherapy and image guided radiotherapy for rectal cancer. Externo

ESTRO technical guideline: intensity modulated radiotherapy and image guided radiotherapy for rectal cancer.

Introduction: Intensity Modulated Radiotherapy (IMRT) and Image Guided Radiotherapy (IGRT) have become an integral part of standard care for rectal cancer, but evidence-based detailed guidance is lacking to support its clinical implementation and use. This European SocieTy for Radiotherapy and Oncology (ESTRO) technical guideline aimed to assess the available evidence and provide recommendations for their use in rectal cancer treatment.

Acceder
ESMO HANDBOOK OF CANCER GENETICS AND GENOMICS Edited by Angela George, David SP Tan, Marcia Hall and Tania Fleitas Kanonnikoff Externo

ESMO HANDBOOK OF CANCER GENETICS AND GENOMICS Edited by Angela George, David SP Tan, Marcia Hall and Tania Fleitas Kanonnikoff

ESMO HANDBOOK OF CANCER GENETICS AND GENOMICS Edited by Angela George, David SP Tan, Marcia Hall and Tania Fleitas Kanonnikoff

Acceder
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors Externo

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors

Acceder
APreciseReirradiationSupportingToolInitiative(PRISTIN)forPrescribingAbsorbedDoseandNumberofFractionsinReirradiation Externo

APreciseReirradiationSupportingToolInitiative(PRISTIN)forPrescribingAbsorbedDoseandNumberofFractionsinReirradiation

APreciseReirradiationSupportingToolInitiative(PRISTIN)forPrescribingAbsorbedDoseandNumberofFractionsinReirradiation

Acceder
•Pediatric ALL Treatment Modifications in Low- and Middle-Income Countries: A Systematic Review Externo

•Pediatric ALL Treatment Modifications in Low- and Middle-Income Countries: A Systematic Review

•Pediatric ALL Treatment Modifications in Low- and Middle-Income Countries: A Systematic Review

Acceder
SEMINARIO EDUCATIVO SOBRE LA IMPORTANCIA DE LA RADIOTERAPIA EN LA ATENCIÓN INTEGRAL DEL CÁNCER. Somera

SEMINARIO EDUCATIVO SOBRE LA IMPORTANCIA DE LA RADIOTERAPIA EN LA ATENCIÓN INTEGRAL DEL CÁNCER.

SEMINARIO EDUCATIVO SOBRE LA IMPORTANCIA DE LA RADIOTERAPIA EN LA ATENCIÓN INTEGRAL DEL CÁNCER.

Acceder
Prognostic value of early treatment response to craniospinal irradiation in diffuse leptomeningeal glioneuronal tumors: a case series Externo

Prognostic value of early treatment response to craniospinal irradiation in diffuse leptomeningeal glioneuronal tumors: a case series

Prognostic value of early treatment response to craniospinal irradiation in diffuse leptomeningeal glioneuronal tumors: a case series

Acceder
Radiotherapy Prescription Dose and Normal Tissue Tolerance Dose Protocol Version 2.0 Externo

Radiotherapy Prescription Dose and Normal Tissue Tolerance Dose Protocol Version 2.0

Radiotherapy Prescription Dose and Normal Tissue Tolerance Dose Protocol Version 2.0, November 2022 Compiled by Dr. Balaji K, PhD Sr. Medical Physicist Gleneagles Global Hospitals, Chennai

Acceder
A National Audit of Current UK Practice on the Use of Anti-Emetics for Chemotherapy-Induced Nausea and Vomiting in Children. Externo

A National Audit of Current UK Practice on the Use of Anti-Emetics for Chemotherapy-Induced Nausea and Vomiting in Children.

A National Audit of Current UK Practice on the Use of Anti-Emetics for Chemotherapy-Induced Nausea and Vomiting in Children.

Acceder
Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study. Externo

Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study.

Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study.

Acceder
PedROC 2.0: provider confidence in Wilms tumor management in sub-Saharan Africa: making the case for pediatric radiotherapy inclusion during basic medical training. Externo

PedROC 2.0: provider confidence in Wilms tumor management in sub-Saharan Africa: making the case for pediatric radiotherapy inclusion during basic medical training.

PedROC 2.0: provider confidence in Wilms tumor management in sub-Saharan Africa: making the case for pediatric radiotherapy inclusion during basic medical training.

Acceder
A Decade of Transformation in the Management of Childhood Acute Lymphoblastic Leukemia: From Conventional Chemotherapy to Precision Medicine. Externo

A Decade of Transformation in the Management of Childhood Acute Lymphoblastic Leukemia: From Conventional Chemotherapy to Precision Medicine.

A Decade of Transformation in the Management of Childhood Acute Lymphoblastic Leukemia: From Conventional Chemotherapy to Precision Medicine.

Acceder
AIEOP-BFM ALL 2017 International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia. Externo

AIEOP-BFM ALL 2017 International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia.

AIEOP-BFM ALL 2017 International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia.

Acceder
Translational advancement of immunotherapeutics against pediatric central nervous system tumors. Externo

Translational advancement of immunotherapeutics against pediatric central nervous system tumors.

Translational advancement of immunotherapeutics against pediatric central nervous system tumors.

Acceder
Radiotherapy Volume Relationships (Platy Graph) Somera

Radiotherapy Volume Relationships (Platy Graph)

The precise definition of target volumes in radiotherapy represents one of the most critical steps in radiation treatment planning, directly impacting treatment efficacy and patient safety. The International Commission on Radiation Units and Measurements (ICRU) has established standardized terminology and protocols through a series of reports (ICRU 50, 62, 71, and 83) to ensure consistency across radiotherapy centers worldwide.

Palliative Medicine and Hospice Care for Physician Associates Somera

Palliative Medicine and Hospice Care for Physician Associates

The palliative care team has been asked to see a 5-year-old boy in the pediatric intensive care unit (PICU) with hypoxic ischemic encephalopathy secondary to a drowning episode 3 years ago. The child is ventilation-dependent, and this is the fifth admission for recurrent pneumonia this year. The family has been very clear about their goals of care but do not feel supported by the medical team

Postmastectomy Radiation Therapy An ASTRO Somera

Postmastectomy Radiation Therapy An ASTRO

As a leading organization in radiation oncology, the American Society for Radiation Oncology (ASTRO) is dedicated to improving quality of care and patient outcomes. A cornerstone of this goal is the development and dissemination of clinical practice guidelines based on systematic methods to evaluate and classify evidence, combined with a focus on patient-centric care and shared decision-making. ASTRO develops and publishes guidelines without

Leucemia Linfoblástica Aguda en niñas, niños y adolescentes Somera

Leucemia Linfoblástica Aguda en niñas, niños y adolescentes

La Leucemia Linfoblástica Aguda (LLA) es el tipo de cáncer más común en la infancia, representa el 75% de los casos de leucemia en niños, niñas y adolescentes 1. Constituye un problema relevante de salud pública debido a su alta incidencia.

Target Volume Delineation for Pediatric cancers Somera

Target Volume Delineation for Pediatric cancers

Recent developments in radiation and neuro-oncology provide the ability to deliver required radiation dose to target volumes for pediatric brain tumors while avoiding sensitive normal central nervous system (CNS) structures uninvolved by tumor. Many CNS target volumes are smaller than in previous years due to better understanding of areas at risk for recurrence or involvement and patterns of spread for a given diagnoses. Advances in neuroimaging and treatment planning software allow for better delineation of tumors and normal neuroanatomy

NCCN Guidelines Version 1.2026 Prostate Cancer Somera

NCCN Guidelines Version 1.2026 Prostate Cancer

NCCN Guidelines Version 1.2026 Prostate Cancer

Lattice Radiation Therapy in clinical practice: A systematic review Somera

Lattice Radiation Therapy in clinical practice: A systematic review

Lattice Radiation Therapy (LRT) is an innovative radiotherapy (RT) technique that allows to concurrently administering ablative doses inside neoplastic lesions and low doses near the adjacent organs at risks (OARs) (See Fig. 1). LRT can be considered as a type of spatially fractionated radiation therapy (SFRT) and it represents the 3-dimensional (3D) configuration of the 2-dimensional (2D) GRID therapy (See Fig. 2) [1]. The heterogeneous dose distribution of a LRT plans entails the creation of a 3D array inside the planning target volume (PTV), where high-dose (vertices or hotspots) and low-dose areas (periphery

Curative Treatment of Pediatric Hodgkin Lymphoma With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Consolidation Radiotherapy Somera

Curative Treatment of Pediatric Hodgkin Lymphoma With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Consolidation Radiotherapy

While COG and Euronet use three risk groups (low, intermediate, and high), the authors chose to dichotomize groups as most included articles categorized patients as limited or advanced disease. Low- and intermediate-risk (IR) diseases in studies describing three risk groups were analyzed within the limited disease group. Each study had their own criteria for risk stratification. Two sets of bias assessments were conducted, using methodologies used by the Pediatric Normal Tissue Effects in Clinic

Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas Somera

Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas

The consensus was discussed during monthly webbased national meetings, and the algorithms were revised until a consensus was achieved. Results: A total of 26 participants were involved in the development of the algorithms. Two treatment algorithms are proposed, one for the initiation of treatment and one for the discontinuation of treatment.

Results with radical conformal radiotherapy in prostate cancer Somera

Results with radical conformal radiotherapy in prostate cancer

Background: Prostate cancer (PCa) is the most common malignant tumor in men in Mexico. There are two treatments with curative potential, such as radical prostatectomy (RP) for localized disease and radical radiotherapy (R-RT). Control rates are determined by the prognostic factors present. Objective: The objective of this study was to determine the control and survival rate with radical conformal radiotherapy (R-CR) in PCa. Methods: The 8.5-year results of an institutional series are presented using Cox proportional hazards analysis and Kaplan-Meier survival.

Establishment of Twinning Partnership to Improve Pediatric Radiotherapy Outcomes Globally Somera

Establishment of Twinning Partnership to Improve Pediatric Radiotherapy Outcomes Globally

Childhood cancer is prevalent throughout the world.1 With modern technologies and therapies, high-income countries (HICs) now report cure rates as high as 80% for children with cancer.2,3 However, low- and middle-income countries (LMICs) struggle with lack of health care resources and infrastructure, resulting in upward of 90% of pediatric oncologic deaths occurring in these countries.2-4 As radiotherapy is a critical component of care for children with malignancies, improving quality and access to pediatric radiotherapy services in LMICs is vital.5 Ethiopia is a low-income country (LIC) in sub-Saharan Africa with a multitude of distinct ethnic groups, languages, and religions

RADIOTERAPIA EN MÉXICO: UNA NECESIDAD URGENTE Y ESTRATÉGICA Externo

RADIOTERAPIA EN MÉXICO: UNA NECESIDAD URGENTE Y ESTRATÉGICA

El cáncer es la tercera causa de muerte en México con más de 91,500 fallecimientos anuales. Uno de cada dos pacientes requiere radioterapia como parte de su tratamiento, pero nuestro país cuenta con apenas 2 equipos por millón de habitantes, cuando la recomendación internacional es de 4. Esto coloca a México en desventaja incluso frente a países de ingresos bajos.

Acceder
Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Somera

Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III

Introduction: Post-treatment surveillance is recommended for NSCLC owing to a high risk of recurrence, but evidence on the optimal surveillance method is lacking. This trial evaluates fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG PET/CT) versus contrast-enhanced CT (ceCT) for surveillance in patients with NSCLC.

Acceder
Irradiación cráneo-espinal pediátrica. Déficit de crecimiento y aspectos dosimétricos. Somera

Irradiación cráneo-espinal pediátrica. Déficit de crecimiento y aspectos dosimétricos.

Antecedentes: La irradiación cráneo-espinal (ICE) tiene un impacto decisivo en el control de tumores pediátricos con alta probabilidad de diseminación por líquido cefalorraquídeo, pero se asocia a defectos del desarrollo de la columna vertebral en etapa de crecimiento. Objetivo: Analizar las alteraciones de columna posteriores a ICE, y la comparación dosimétrica de las técnicas de radioterapia conformada (RC) y arco volumétrico de intensidad modulada (VMAT).

Acceder
Emerging Role of Targeted Therapies Combined With Radiotherapy in Inoperable Stages I to III NSCLC: A Review From the IASLC ART Subcommittee. Somera

Emerging Role of Targeted Therapies Combined With Radiotherapy in Inoperable Stages I to III NSCLC: A Review From the IASLC ART Subcommittee.

Precision oncology has transformed the management of NSCLC by tailoring treatment to the specific genetic alterations driving oncogenesis. Targeted therapies, such as tyrosine kinase inhibitors, have been found to dramatically improve survival in patients with advanced-stage NSCLC.

Acceder
Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors Somera

Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors

Summary Background In postmenopausal women with oestrogen receptor-positive early breast cancer, 5 years of adjuvant tamoxifen substantially reduces 15-year recurrence and mortality; aromatase inhibitor treatment (AIT) is even more effective. We assess the effects of further AIT among women recurrence-free after at least 5 years of endocrine therapy

Acceder
Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases – A Case-Based Radiosurgery Society Practice Guide and Review Somera

Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases – A Case-Based Radiosurgery Society Practice Guide and Review

AstraZeneca. He received travel support from the Radiosurgery Society. He is member of the data safety monitoring board or advisory board for Genentech, ViewRay, AstraZeneca, and Roche. He holds leadership or fiduciary roles in the Radiosurgery Society and ASTRO. Ben J. Slotman is president of the Radiosurgery Society.

Acceder
Stereotactic Radiation Therapy in Children and Young Adults: Can We Apply Adult Treatment Paradigms? Somera

Stereotactic Radiation Therapy in Children and Young Adults: Can We Apply Adult Treatment Paradigms?

a Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; b Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio; c Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; d Department of Radiation Oncology, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa; e Department of Radiation Oncology, Stanford University, Stanford, California; and f Department of Radiation Oncology, University of California San Francisco, San Diego, California

Acceder
Plasma Epstein-Barr Virus DNA Temporal Clearance Pattern During Induction-Concurrent (Chemo) Somera

Plasma Epstein-Barr Virus DNA Temporal Clearance Pattern During Induction-Concurrent (Chemo)

Purpose: Plasma Epstein−Barr virus (EBV) DNA is a widely used biomarker for nasopharyngeal carcinoma (NPC). Prior investigations predominantly assessed EBV DNA at a single time point, thus neglecting the differential prognostic implications of the temporal clearance pattern of EBV DNA during induction-concurrent (chemo)radiation therapy (RT).

Acceder
NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation Somera

NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation

Corresponding author: Matthew Poppe, MD; E-mail: matthew. poppe@hci.utah.edu This protocol is registered with ClinicalTrials.gov and may be viewed online at https://clinicaltrials.gov/study/NCT03345420 Author Responsible for Statistical Analysis: Kenneth Boucher, PhD. Disclosures: M.M.P. is an investor in PEEL Therapeutics, Inc., and K.E. B. serves as a consultant for Impedimed. M.M.P. also reports the following roles and associations: Vice Chair, Breast Committee, Alliance; Co-Chair, Breast Locoregional Working Group, Alliance; Member, Executive Committee and Board of Directors, Alliance; Member,

Acceder
Association of Multi-Kingdom Skin Microbiota With Radiation Dermatitis in Patients Somera

Association of Multi-Kingdom Skin Microbiota With Radiation Dermatitis in Patients

Background: The clinical significance of multi-kingdom skin microbiota in acute radiation dermatitis (ARD) is not well understood. We hypothesized that skin microbiota is associated with ARD in patients with breast cancer (BC) undergoing radiation therapy (RT) after reconstructive surgery

Acceder
Guía para el manejo del dolor en pequeños procedimientos en pediatría Externo

Guía para el manejo del dolor en pequeños procedimientos en pediatría

Guía para el manejo del dolor en pequeños procedimientos en pediatría. Dirigida a profesionales. DIRECCIÓN Y COORDINACIÓN Pilar Hilarión Subdirectora. Instituto Universitario Avedis Donabedian - Universitat Autònoma de Barcelona. Red de investigación en servicios de salud en enfermedades crónicas (REDISSEC) Carola Orrego Subdirectora. Instituto Universitario Avedis Donabedian - Universitat Autònoma de Barcelona. Red de investigación en servicios de salud en enfermedades crónicas (REDISSEC) Área Social de la Fundación Bancaria “la Caixa”.

Acceder
Neurocognitive Effects and Necrosis in Childhood Cancer Survivors Treated With Radiation Therapy Somera

Neurocognitive Effects and Necrosis in Childhood Cancer Survivors Treated With Radiation Therapy

The definitive management of many pediatric malignancies requires radiation therapy (RT) to the central nervous system (CNS) that may predispose survivors to neurologic complications. A detailed understanding of radiation dosevolume effects is required to maximize the therapeutic ratio of brain irradiation.

Neurocognitive Late Effects of Chemotherapy in Children Somera

Neurocognitive Late Effects of Chemotherapy in Children

Treatment protocols for childhood cancer have changed rapidly over the years, maintaining a balance between effective therapy and acceptable toxicity.

Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy Somera

Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy

As cancer survival rates continue to improve, longterm adverse effects of treatment on health and quality of life are increasingly important considerations for clinicians, patients, and familymembers. Neurocognitive deficits (NCD) are well established as a common adverse effect in brain tumor survivors, owing to the tumor itself, but also localized brain irradiation treatment.

Radiation-Induced Cognitive Decline: Challenges and Solutions Somera

Radiation-Induced Cognitive Decline: Challenges and Solutions

Abstract: Radiation therapy, a common treatment for central nervous system cancers, can negatively impact cognitive function, resulting in radiation-induced cognitive decline (RICD). RICD involves a decline in cognitive abilities such as memory and attention, likely due to damage to brain white matter, inflammation, and oxidative stress

Radiation-Induced Brain Injury: Age Dependency of Neurocognitive Somera

Radiation-Induced Brain Injury: Age Dependency of Neurocognitive

Simple Summary: Radiation therapy-related brain damage with neurocognitive impairment is a common long-term side effect in cancer survivors and significantly impairs the quality of life. Increasing evidence indicates the increased vulnerability of the developing brain to the neurotoxic effects of ionizing radiation (IR).

Neurocognitive Decline Following Radiotherapy: Mechanisms and Therapeutic Implications Somera

Neurocognitive Decline Following Radiotherapy: Mechanisms and Therapeutic Implications

Abstract: The brain undergoes ionizing radiation (IR) exposure in many clinical situations, particularly during radiotherapy for malignant brain tumors. Cranial radiation therapy is related with the hazard of long-term neurocognitive decline.

FAST-Forward Boost Somera

FAST-Forward Boost

FAST-Forward Boost A randomised clinical trial testing a 1-week schedule of curative simultaneous integrated boost radiotherapy against a standard 3-week schedule in patients with early breast cancer.

Guidelines on Prostate Cancer Somera

Guidelines on Prostate Cancer

EAU - EANM - ESTRO - ESUR - ISUP - SIOG Guidelines on Prostate Cancer

CONSENSO CANCER MAMA 2025 Somera

CONSENSO CANCER MAMA 2025

CONSENSO MEXICANO SOBRE DIAGNÓSTICO Y TRATAMIENTO DEL CÁNCER MAMARIO UNDÉCIMA REVISIÓN, ENERO 2025. RADIOONCOLOGÍA: Dra. Adela Poitevín Chacón Radiooncóloga Médica Sur, Ciudad de México. Dra. Christian Haydeé Flores Balcázar Radiooncóloga Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, SS., Ciudad de México.

TNM Classification of Malignant Tumours 9th Edition Externo

TNM Classification of Malignant Tumours 9th Edition

TNM Classification of Malignant Tumours 9th Edition Edited by: James Brierley, Meredith Giuliani, Brian O'Sullivan, Brian Rous, Elizabeth Van Eycken WILEY

WhatsApp
Logo

Enlaces

cmcro.com.mx amlcc.org cmo.org.mx smeo.org.mx Consenso Mexicano sobre Diagnóstico y Tratamiento del Cáncer Mamario

Enlaces

fucam.org.mx juntoscontraelcancer.mx estro.org teramac.com.mx

Dirección

Durango 209, piso 3, Roma Nte., Cuauhtémoc, 06700 Cuauhtémoc, CDMX

Correo

someramexico@gmail.com

Teléfono

+52 55 1827 8370

Compromiso

Transformando el futuro de la radioterapia y consolidando una red de colaboración que impulse la innovación.

Somera, Todos los derechos reservados.